Phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pretreated patients with metastatic colorectal cancer.
Kazuhisa Yamaguchi
No relevant relationships to disclose
Hiroya Taniguchi
No relevant relationships to disclose
Azusa Komori
No relevant relationships to disclose
Yukiya Narita
No relevant relationships to disclose
Shiori Uegaki
No relevant relationships to disclose
Sohei Nitta
No relevant relationships to disclose
Motoo Nomura
No relevant relationships to disclose
Shigenori Kadowaki
No relevant relationships to disclose
Daisuke Takahari
No relevant relationships to disclose
Takashi Ura
No relevant relationships to disclose
Masashi Andoh
No relevant relationships to disclose
Kei Muro
No relevant relationships to disclose